Clinical significance of myocardial perfusion abnormalities in patients with varying degree of coronary artery stenosis

Nuclear Medicine Communications

Volumn 29, Issue 2, 2008, Pages 129-136

  Rasulova, Nigora ^a   Singh, Aviral ^a   Demetriadou, Ourania ^a   Georgiou, George ^b   Yiannakkaras, Charalambos ^b   Khodjibekov, Marat ^c   Al Nahhas, Adil ^c  

^a Republic Specialized Centre of Surgery   (United Kingdom)

^b CANBERRA HOSPITAL   (Australia)

^c IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Coronary artery disease; Insignificant coronary artery stenosis; Myocardial perfusion scintigraphy; Selective coronary angiography

Indexed keywords

CHLORIDE TL 201; RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M; THALLIUM 201; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL EXAMINATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY RISK; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; SEX RATIO;

AGED; ANGIOGRAPHY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MYOCARDIUM; PERFUSION; RADIONUCLIDE IMAGING; RISK; RISK FACTORS;

EID: 37349032154     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3282f30461     Document Type: Article

References (24)

1. Bugiardini R, Bairey Merz CN. Angina with ‘normal’ coronary arteries: a changing philosophy. JAMA 2005; 293:477-484.
2. Brown KA, Osbakken M, Boucher CA, Strauss HW, Pohost GM, Okada RD. Positive exercise thallium-201 test responses in patients with less than 50% maximal coronary stenosis: angiographic and clinical predictors. Am J Cardiol 1985; 55:54-57.
3. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16:434-44.
4. Nissen SE. Digital angiography: Principles and clinical applications. In: Pepine CJ, Hill JA, Lambert CR (editors): Diagnostic and Therapeutic Cardiac Catheterisation. Baltimore: Williams and Wilkins; 1997, pp. 185-202.
5. Campeau L. Grading of angina pectoris. [Letter] Circulation 1976; 54:522-523.
6. Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997; 96:3390-3395.
7. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilatation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995; 91:2345-2352.
8. Soman P, Dave DM, Udelson JE, Han H, Ouda HZ, Patel AR, et al. Vascular endothelial dysfunction is associated with reversible myocardial perfusion defects in the absence of obstructive coronary artery disease. J Nucl Cardiol 2006; 13:756-760.
9. Wu WC, Sharma SC, Choudhary G, Coulter L, Coccio E, Eaton CB. Flow-mediated vasodilation predicts the presence and extent of coronary artery disease assessed by stress thallium imaging. J Nucl Cardiol 2005; 12:538-544.
10. Treasure CB, Vita JA, Cox DA, Fish RD, Selwyn AP, Alexander RW, Ganz P. Acute myocardial infarction with normal coronary arteries associated with acetylcholine-induced vasoconstriction in the absence of a positive ergonovine test. Am J Cardiol 1990; 65:255-257.
11. Landmesser U, Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol 2005; 20:547-551.
12. Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med 1995; 332:512-521.
13. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003; 42:1149-1160.
14. Madsen MM, Bottcher M, Toftegaard Nielsen T, Czernin J. Altered regulation of the myocardial microcirculation in young smokers. Cardiology 2000; 94:91-98.
15. Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, Deanfield JE. Cigarette smoking is associated with dose-related and potentially reversible impairement of endothelium-dependent dilation in healthy young adults. Circulation 1993; 88:2149-2155.
16. Zeiher AM, Schachinger V, Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 1995; 92:1094-1100.
17. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation 2001; 104:191-196.
18. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105:32-40.
19. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168-175.
20. Gimbrone Jr MA, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann NY Acad Sci 2000; 902:230-239.
21. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001; 38:1872-1878.
22. Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, et al. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA 1995; 274:894-901.
23. Levine GN, Frei B, Koulouris SN, Gerhard MD, Keaney JF Jr, Vita JA. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 1996; 93:1107-1113.
24. Cohen JD, Drury JH, Ostdiek J, Finn J, Babu BR, Flaker G, et al. Benefits of lipid lowering on vascular reactivity in patients with coronary artery disease and average cholesterol levels: a mechanism for reducing clinical events? Am Heart J 2000; 139:734-738.